<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 79 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page78.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=79">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 79 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 79</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=79"><img src="../thumb/79.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>48 / 2020-04                                                      Central Nervous System - 1.9 / 1.10
   betw.dos. & max. of 2x2,5 mg/24 hrs.not to be exceed. A 2nd dos.  Drug interactions: Poss.sev.seroton.syndr.with concom.SSRI’s/SN-  Dosage: Rapimelt orally dispers.tabs are dissolv. in mouth & in-
   has not shown to provide relief if the 1st dos. did not have a benefic.  RI’s, undesir.reacts.with St John’s Wort, addit.effs.to ergotam./ergot   dicat.when water is not avail./if pt. unable to drink. Signific.effic.
   respons. Recomm. dos. not to be exceed.  derivat./ & other 5-HT1D agon., select.& non select.revers. MAOI’s   evid.within 1 hr.of dos.
   Contraindications: Prev.MI/ischaem.heart dis., prinzmetal ang./   incr.plasma conc., plasma conc.incr.with concom. propanolol, consid.  Recomm.dos: 2,5 mg. If respons.unsatisfact.with 2,5 mg dos. sub-
   coron vasosp., periph.vasc. dis./ sympts. & sign.consist.with ischaem.  potent.interact.with CYP2D6 substrates.  seq. attacks can be treat.with 5 mg. If sympts.persist/return within 24
   heart dis., CVA, trans.ischaem. attack, uncontr.hypertens., sev. imp.  hrs.a 2nd dos. may be tak.2 hrs.aft.init.dos. Total intake not to exceed
   ren./hepat.funct., concom.ergotamine preps./ derivat.& sumatriptan   SIBELIUM, Janssen Pharmaceutica [P/S]  10 mg/24 hrs & 5 mg/24 hrs.in mild hepat. impairm.
   not recomm., safety in pregn.& pts.over 65 yrs.not est., sulphonam.   Flunarizine HCl.equiv.to flunarizine.  Contraindications: Sev.hypertens., ischaem. heart dis., coron.
   hypersens., not recomm.for childr. und. 12 yrs.or adolesc.12-17 yrs.,   Indications: Classic (with aura)/common(without aura) migraine   vasospasm/Prinzmetal’s ang., mod. to sev.hepat.impairm., symp-
   poss.unrecogn. card. dis.without prior evaluat.  prophylax., vestib.vertigo due to diagnos.vestibul.syst.funct.disord.  tomat.Wolff-Parkinson-White syndr., card.accessory conduct.
   Side effects: Chest/throat pain,.sensat.of tingl. & heat, heavin.  (S2) T-5 mg TABS, [P/S] .43/5.7.1/0451  pathway assoc.arrhythm., safety in pregn.& lactat. not est., not for
   press./tightn., N & V, drowsin., hypersens.reacts.  718100-001: 5 mg, 60, R813,14  prophylax., safety & effic.in childr. /adolesc. 12 -17 yrs. Rapimelt
   Special precautions: Lactat., only use in clear diagn., not for use in   (S2) TABS, [P/S] M/5.7.1/530.  tabs also: phenylketonuria as tabs contain phenylalanine, hemi-
   managem.of hemipleg., basil. or opthalmopleg.migraine., excl.other   825026-008: 10 mg, 28, R762,49  pleg./ basilar migraine.
   potent. ser.neurologic.condit.  Dosage: Do not exceed recomm.dos.  Side effects: Coron. vasospasm, ang.pect., MI, abnormalit./disturbs.
                                Migraine prophylax: Start.dos: Und.65 yrs: 10 mg at night.   of sensat., dizzin., paraesthes., somnol., warm sensat., headache,
   RELPAX, Pfizer [P/S]         Over 65 yrs: 5 mg.dly. If no respons. observ.aft.2 mnths.discont.ther.  palpitat., dry mouth, N&V, dysphag., dyspeps., abdom. pain, musc.
   Eletriptan.                  Maint: Aft.satisfact.respon.& if maint.reqd.admin. same dly.dos.for   weakn., myalg., asthen., heavin., tightn., pain/press.in throat, neck,
   Indications: Ac migraine attacks with/without aura.  only 5 days/wk.with 2 consec. med.free days/wk. Treatm.should be   limbs or chest, tachycard., trans.BP incr., polyur., ren./urin. disords.
   (S4) TABS. 34/7.3/0079       interrupt.aft. 6 mnths.& only re-instat.if pt.relapses.  incl.incr.urin.freq./urg., anaphylax/ anaphylact. reacts., hypersens.
   702164-006: 80 mg, 4, R417,84  Vertigo: Admin.same dly.dos.as for migraine but start. treatm.should   reacts., angioed., urticar., GI disords., cerebr./subarachn.haemorrh.,
   Dosage: Do not use prophylact. Swallow whole. Treatm.must be   not be given.for longer than reqd.to contr.sympts.which is gen.less   stroke, other cerebrovasc.events, atypic.sensat. over precordium
   taken soon aft.onset.of headache only dur.headache phase.  than 2 mnths. If no respons.observ.aft.1 mnth.for chron. vertigo/2   Special precautions: Coron.vasosp.& MI assoc. with this class
   Adults 18-65 yrs: Recomm.init.dos: 40 mg. If aft. init.respons.head-  mnths.for paroxysmal vertigo discont. ther.  of compds.theref.CV evaluat.of pts. with ischaem.heart dis.risk fact.
               nd
   ache returns within 24 hrs.a 2  dos. may be taken if necess.at least   Contraindications: Depress.illn., pre-exist. sympts. of Parkinson’s/   recomm., ser.card. events in pts.with underly.CV dis., caref.observat.
   2 hrs.aft.init. dos. Do not rep.dos.for same attack if no respons. ex-  other extra-pyramid. disords.  with concom.SSRI/SNRI’s for seroton.syndr., use in elderly not evalu-
           st
   per.within 2 hrs.of 1  dos. Pts.not exper. satisfact.respons.to 40 mg   Side effects: Weight incr., somnol., depress., incr.appet., rhinit.,   at., concom.5HT1B/1D agonists within 12 hrs. to be avoid., 24 hrs.should
   may incr.dos.to 80 mg for subseq.attack. Max.dly.dos: 160 mg. In pts.  constip., stomach discomf., myalg., irreg.menstruat., breast pain/-  lapse betw. tak. ergotamine /ergot type meds., 6 hr. interv. betw. tak.
   receiv.concom.erythromycin & other specif. potent CYP3A4 inhibit.  hypertrophy, fatig.,depress.sympt., sleep disord., apathy, abnorm.   ergotamine prep., interacts.with inhibit. of cytochrome P450 isoen-
   recomm.dos.is 20 mg & tot. dly intake should not exceed 40 mg.  co-ordinat., disorientat., lethargy, paraesthes., restlessn., sluggishn.,   zyme CYP1A2 cannot be excl., excl.other ser.neurolog.condits.1 , only
                                                                                       st
   Contraindications: Sev.hepat.impairm., uncontrol. hypertens., con-  tinnit., torticoll., palpitats., intestin.obstruct., dry mouth, GI disord., hy-  use where a clear diagn.of migraine est.
   firm./suspect.coron. heart dis.incl.ischaem.heart dis./ prev.MI,, coron.  perhidros., musc.spasm/twitch., menorrhag., menstr. disord., oligome-  Drug interactions: Ergot contain.drugs.prolong. vasospast.reacts.,
   artery vasosp., prinzmetal ang.pect., periph.vasc.dis., periph.arter.in-  norrh., decr.libido, gen./ periph. oed., asthen., insomn., anx., akathis.,   max.of 5 mg/24 hrs.with concom. MAO-A inhibit.(e.g moclobemide),
   suffic., CVA, trans. ischaem. attack, concom.ergotamine preps. /deri-  bradykines., cogwheel rigidity, dyskines., essen. trem., extrapyramid.   max.of 5 mg/ 24 hrs with cimetidine as half-life of zolmitriptan &
   vat. within 24 hrs., other concom.5-HT 1 recept. agon., potent CYP3A4   disord., Parkinsonism, sedat,, trem., hypotens., naus., musc.rigidity,   act.metabol.signific.incr., life threat. seroton. syndr.report.with con-
   inhibit.eg. ketoconazole/ itraconazole/erythromycin/ clarithromycin &   erythema, galactorrh.  com.SSRI & SNRI’s.
   protease inhibit., HF pts., childr. & adolesc.&lt;18 yrs.,  Warnings and special precautions: Not suit.for abort.migraine
   Side effects: Common: Dizzin., headache, hyperton., hypoesthes.,   attack, poss.extrapyramid.& depess. sympts.& may reveal Parkinson.
   myasthen., paraesthes., somnol., vertigo, palpitat., tachycard., sensat.  in predispos. pts eg.elderly, depress., concurr. phenothiazin., discont.
   of warmth/flush., pharyngit., throat tightn., abdom. pain, dry mouth   ther.if fatig.incr.progress., discont. if depress./extrapyramid.sympts  1.10   Alzheimer’s disease
   dyspeps., naus., sweat., back pain, myalg., asthen., chest sympts.,   occur/ therapeut.eff.subsid., lact.intol., safety in pregn. not est., do
   chills, pain. Post market: Allerg.react.poss.ser.with angioed., syn-  not take when breastfeed.  EBITINE (MDR Listing)
   cope, hypertens., vomit., ischaem. colit., myocard.ischaem./-infarct.,   Drug interactions: Alcoh.& other CNS depress. aggrav.drowsin., ga-  EBIXA (MDR Listing)
   coron. arteriosp., prurit., rash, urticar.  lactorrh.with OC’s within 1  2 mnths., metabol.incr.by carbamazepine   ARICEPT, Pfizer [P/S]
                                           st
   Warnings and special precautions: Other concom. meds.with   & phenytoin., extrapyramid.S/E with phenothiazin.  Donepezil HCl
   serotonerg.activ.as seroton. syndr.report., only use in clear migraine   Indications: Symptomat.treatm.of dementia of Alzheimer’s dis.
   diagn., not for use in managem.of hemipleg./basilar migraine.,   ZOLMIFOR ODT, (Forrester) LeBasi [P/S]  (S5) TABS. 32/5.3/0315, 0316.
   atypic. headaches poss.relat.to serious condits. where cerebrovasc.  Zolmitriptan.  837326-001: 5 mg, 28, R686,98
   vasoconstrict.poss. harmful, CV eval.where card.dis.likely/pts.at risk,   Indications: Ac.migraine treatm.with/without aura.  837334-004: 10 mg, 28, R734,47
   poss.incr.BP esp.in elderly & ren.impairm., overuse report.in pts.with   (S4)ORODISP.TABS. 45/7.3/1119  Dosage: 5-10 mg once dly.in even.prior to retir. Init.5 mg/day for at
   chron.dly.headache, driv./ operat. machin., lact.intol.& hypoglycaem.   724011-011: 2,5 mg, 6, R189,61  least 4-6 wks.to assess treatm.aft.which dos.may be incr.to 10 mg/
   contr. of diabet., safety in pregn.not est., excret. in breast milk, safety   Dosage: Orodispers.tabs are dissolv.on tongue & indicat. when wa-  day. Max recomm.dly.dos.is 10 mg.
   & effic.in pts.over 65 yrs. not eval., dos.over 40 mg in ren.impairm  ter is not avail./if pt.unable to drink. Take as early as poss.aft.onset of   Contraindications: Piperidine derivat. hypersens., safety in pregn.&
   Interactions: Signific.incr.in C max & AUC with potent inhibit of CY-  migraine headache. Signific.effic.evid.within 1 hr.of dos.  lactat.not est., safety & effic.in childr.not est.
   P3A4 erythromycin /ketoconazole/ itraconazole/clarithromycin/ rito-  Recomm.dos: 2,5 mg. If respons.unsatisfact. with 2,5 mg dos.sub-  Side effects: Common cold, flu., dehydrat., psych. disords.incl.in-
   navir/ indinavir & nelfinavir., concom. ergotamine preps./derivat.not to   seq.attacks can be treat.with 5 mg. If sympts.persist/return within 24   somn./hallucinat./agitat./depress./ aggress.behav./abnorm.cry.& incr.
   be taken within 24 hrs. of admin., co-admin.of meds.with serotonerg.   hrs.a 2nd dos. may be tak.2 hrs.aft.init.dos. Total intake not to exceed   libido,, dizzin., headache, somnol., aphas., atax., paraesthes., syncope,
   activ.incr.seroton. syndr.risk.  10 mg/24 hrs & 5 mg/24 hrs.in mild hepat. impairm.  trem., seiz., cataract, eye irrit., blurr.vis., vertigo, AV-/sino-atrial block,
                                Contraindications: Sev.hypertens., ischaem. heart dis., coron.va-
   RIZATRIPTAN MYLAN ODT 10 mg, Mylan [P/S]  sospasm/Prinzmetal’s ang., mod. to sev.hepat.impairm., hist.of CVA/  bradycard., hot flush., hypertens., hypotens., vasodilat., dyspn., sore
   Rizatriptan.                 TIA, concom. ergotamine & derivat/other 5-HT 1 recept. antagon.,   throat, GI disturbs.incl.haemorrh., toothache, gastric/duod.ulc., hep-
                                                              atit., diaphores., ecchymos., prurit., urticar., musc.cramps, freq.urinat.,
   Indications: Ac treatm.of headache phase of migraine attacks   symptomat.Wolff-Parkinson-White syndr., card.accessory conduct.
   with/without aura.           pathway assoc. dysrhythm., safety in pregn.& lactat.not est., not for   nocturia, urin.incontin., fatig., pain, chest pain, weight decr., min.incr.
                                                              in ser.conc.of musc.creat.kinase, accident, bone fract.
   (S4) ORO DISP TABS, 46/7.3/0218.  prophylax., safety & effic.in childr./adolesc. 12 -17 yrs. not est., phe-
   722337-001: 10 mg, 3, R187,07  nylketonuria as contain phenylalanine, hemipleg./basilar migraine.  Warnings and special precautions: Treatm.by exper.drs.only,
                                                              maint.treatm.may be cont.for as long as therapeut.benef.exists, re-
   722337-002: 10 mg, 6, R374,15  Side effects: Coron.vasospasm, ang.pect., MI, abnormalit./ disturbs.
   Dosage: Do not admin.as prophylax. Eff.delay by food.  of sensat., dizzin., paraesthes., somnol., warm sensat., headache,   assess.on reg. basis, consid.discont.when evid.of therap.eff.no long.
                                                              present, use in other types of dement.or memory impairm.not est.,
   Adults & adolesc.18 yrs & old: Recomm.dos:  palpitat., dry mouth, N&V, dysphag., dyspeps., abdom. pain, musc.
   5-10 mg.                     weakn., myalg., asthen., heavin., tightn., pain/press.in throat, neck,   succinylcholine-type musc. relax.dur.anaesthes.poss.exagger., sick-
                                                              sinus syndr./other supraventric.card.conduct. condits. due to poss
   For headache.recurr.within 24 hrs.aft.relief of init attack a furth.dos.  limbs or chest, tachycard., trans.BP incr., polyur., ren./ urin. disords.
   may be taken so long as each dos.is separat.by at least two hrs.   incl.incr.urin.freq./urg., dyspn., anaphylax/ anaphylact.reacts., hyper-  vagoton.effs.on heart rate, syncopal. episode report., as gastric acid
                                                              produc. promot. monit.for act./occult GI bleed sympts.esp. where
   Max: 2 dos./24 hrs.          sens. reacts., angioed., urticar., GI disords., cerebr./ subarachn.haem-
   Effectiven.of a 2nd dos.where init.dos.ineffect.not exam.in control.  orrh., stroke, other cerebrovasc. events, atypic.sensat.over precordium  ulc.risk incr., poss.bladd.outflow obstruct., cholinomimet. have gen.
                                                              convuls.potent.but seiz. activ.poss. Alzheimer’s manifestat., asthma
   trials theref.do not admin.2  dos. for same attack.  Warnings and special precautions: Risk of cerebrovasc. events,
              nd
   Pts on propranolol./mild to mod ren/hepat.insuffic. to receiv   coron.vasosp./ang.pect.& MI assoc. with this class of compds.theref.  hist., obstruct.pulm.dis., avoid concom. acetylcholinester. inhibit.&
                                                              agonists/antagon.of cholinerg. syst., treat.dr to routine.eval.pts.abil-
   low.5 mg dos.                CV evaluat. with ischaem.heart dis.risk fact.recomm., ser.card. events   ity to driv.& operat.complex machines.
   Contraindications: Concurr.MAOI’s/within 2 wks. of discont., sev.  with underly.CV dis., caref. observat. with concom. SSRI/SNRI’s for   Drug interactions: Inhibit.of CYP450/3A4 & 2D6 (e.g. ketoconazole,
   hepat./ren.insuffic., prev. CVA/ TIA, uncontrol.hypertens., est.coron.artery   seroton. syndr., use in elderly not evaluat., concom. 5HT 1B/ 1D agonists   quinidine/itraconazole/ erythromycin & fluoxetine) may inhibit.me-
   dis. incl.ischaem.heart dis., S&S of ischaem.heart dis./ Prinzmetal’s ang.,   within 12 hrs.to be avoid., 24 hrs. should lapse betw.tak.ergotamine/  tabol., Induc.of CYP3A4 & 2D6 (phenytoin/ carbamazepine/ alcoh./
   safety in pregn.& lactat. not est., not recomm.for pts.und.18 yrs.of age,   ergot type meds., 6 hr. interv.follow.use of zolmitriptan bef. tak. ergot-  dexamethasone/rifampicin & phenobarbit.)may incr.eliminat., poss.
   periph. vasc.dis., other concom.5-HT1D agon./ergotamine/ergot derivat.  amine-contain.prep., interacts.with inhibit. of cytochrome P450 iso-  interfer. with anticholinerg.meds., synergist.eff.when giv. concurr.with
   Side effects: Hypersens., anaphylax., disorient., insomn., nervousn.,   enzyme CYP1A2 cannot be excl., excl.other ser.neurolog.condits. 1 ,   succinylcholine/similar neuromusc. block.agents/ cholinerg.agonists
                                                            st
   dizzin., somnol., paraesthes., headache, hypaesthes., decr.ment.acu-  only use where a clear diagn.of migraine est., excess. use may lead to   (e.g. bethanechol.) /ß-block.which aff.card.conduct.
   ity, trem., atax., vertigo, syncope, dysgeus., seroton.syndr., seiz., blurr.  incr.freq.of headache, poss. undesir.effs.with concom.St Johns Wort
   vis., palpitat., tachycard., dysrhythm., myocard.ischaem., cerebr.vasc.  Interactions: Ergot contain.drugs.prolong. vasospast. reacts., max.  ARIMENTIA, (Aspen Pharma) Pharmacare [P/S]
   incid., hot flush., hypertens., periph.vasc.ischaem., pharyng. discomf.,   of 5 mg/24 hrs.with concom. MAO-A inhibit.(e.g moclobemide) as   Donepezil HCl
   dyspn., wheez., GI disturbs., thirst, dyspeps., ischaem.colit., flush.,   AUC of both meds.poss incr., max.of 5 mg/24 hrs with cimetidine as   Indications: Symptomat.treatm.of mild to mod. dement.in Alz-
   sweat., prurit., urticar., rash, tox.epiderm.necrolys., musculoskelet.   half-life of zolmitriptan & act. metabol. signific.incr., life threat.sero-  heimer’s dis.
   disords.incl.region.heavin.& tightn., chest/neck/facial/abdom.pain,   ton. syndr. report. with concom.SSRI & SNRI’s.  (S5) TABS. 43/5.3/0487; 0488
   stiffn., musc. weakn.,asthen./fatig.                       720802-001: 5 mg, 30, R385,83
   Warnings and special precautions: Do not admin.in basilar/  ZOMIG, AstraZeneca [P/S]  720803-001: 10 mg, 30, R382,77
   hemipleg.migraine, atypic., headaches that may be assoc.with ser.  Zolmitriptan.  Dosage: Admin.once dly.in even.prior to retir.
   medic. condits., cardiovasc.assessm.in pts.at coron.artery dis.risk bef.  Indications: Ac.migraine treatm.with/without aura.  Init.5 mg/day for at least 1 mnth.to assess treatm. & to achieve
   treatm., co-admin.of ergotam.type meds. within 6 hrs.not recomm.,   (S4) TABS. 32/7.3/0478.  steady state conc.aft.which dos.may be incr.to 10 mg/day. Max
   allow 24 hrs.aft. ergotam.contain.meds.admin., caref.pt.monit.in case   845213-016: 2,5 mg, 6, R526,09  recomm.dly.dos.is 10 mg.
   of concom.SSRI’s/SNRI’s esp.dur.init.treatm. & dos. incr., phenylke-  (S4) RAPIMELT TABS, 34/7.3/0107  Contraindications: Piperidine derivat. hypersens., safety in pregn.&
   tonur., safety in pregn.& lactat.& pts.over 65 yrs.not est.  897005-012: 2,5 mg, 6, R383,44  lactat.not est., not recomm. in childr.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page78.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>&nbsp;&nbsp;&nbsp;<a href="page75.html">75</a>&nbsp;&nbsp;&nbsp;<a href="page76.html">76</a>&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>&nbsp;&nbsp;&nbsp;<a href="page80.html">80</a>&nbsp;&nbsp;&nbsp;<a href="page81.html">81</a>&nbsp;&nbsp;&nbsp;<a href="page82.html">82</a>&nbsp;&nbsp;&nbsp;<a href="page83.html">83</a>&nbsp;&nbsp;&nbsp;<a href="page84.html">84</a>
             </td>
             <td width="35%"><a href="page80.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page80.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
